The Allogeneic Cell Therapies Summit

Making allogeneic therapies the gold standard

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

We've now started the tracks of our second day. Thanks to everyone who's taken part so far, looking forward to the rest!

[Atara Bio @Atarabio]

Atarian @blake_aftab will discuss how we're working to advance the next frontier in off-the-shelf, allogeneic #Tcell #immunotherapies alongside industry experts during a fireside chat at today's @AllogeneicCell Therapies Summit! #Celltherapy #CART #EBV #MS #PTLD

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

We're live! Some pretty exciting conversations happening right now at the #AllogeneicCellTherapies Summit. You can still register here: https://t.co/ep1apSlJ7O

[NMDP BioTherapies @nmdp_biotherap]

Joy Aho, our Senior Product Manager, is presenting at @AllogeneicCell's #ACTSummit! Tune into her discussion, "The Allo-Evolution," tomorrow (10/27) at 2 p.m. EST/1 p.m. CST. More info/how to watch: https://t.co/MGO2hkt576

[Dark Horse Consulting Group @darkhorsecagt]

Last but not least, our own Uzma Shoukat-Mumtaz will be attending @AllogeneicCell's #ACTSummit (Oct 26-28th, EST). What a wealth of virtual conferences we've seen this year: a testament to our collective ability to adapt and stay connected. (4/4)

[Cellectis @cellectis]

@ArthurStril, Chief Business Officer of @Cellectis, will present at the @AllogeneicCell conference on October 27th, 2020, at 9 AM EST. To register, click here: https://t.co/tncc8hkiaw

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

The Allogeneic Cell Therapies Summit is running next week! Looking forward to reconnecting with everyone. You call still register and have a look at the agenda below:
https://t.co/SoqwAcUykV #Allogeneic #CellTherapy #ACTSummit #OnlineNetworking

[MSCRF @MD_Stem_Cell]

We are happy to collaborate with @AllogeneicCell meeting next week https://t.co/HgzYE12Dnz

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

Ready to move on from talking about the "new normal" and get started on what comes next? Join us to advance your pipeline and work on the future of cell therapies https://t.co/rPNUDNs5Ch #Allogeneic #CellTherapies #DigitalEvent

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

#celltherapies #stemcells #covid19 #allogeneic #allogeneiccelltherapiessummit #ACT2020

https://t.co/J2UCXc1V7y

[Genetic Engineering & Biotechnology News @GENbio]

GEN's #COVID19 DRUG & VACCINE CANDIDATE TRACKER keeps up with more than 200 potential therapeutics in development against the virus: https://t.co/fGiWs2hORv

[Gene Therapy Net @genetherapynet]

The digital 2nd Allogeneic Cell Therapies Summit (Oct 26-28) is the only meeting completely focused on advancing the development of off-the-shelf therapies by advancing cryopreservation techniques and decreasing cost through industrialized manufacturing. https://t.co/tp2YzEwZSp

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

We have 7 discounted passes left for the Digital Allogeneic Cell Therapies Summit! Get your place by tomorrow: https://t.co/Cxs4tTUNsx

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

The Allogeneic Cell Therapies Summit is now digital! Check out the full event guide for the updated agenda here ➡️ https://t.co/wzTPVht482 #allogeneic #celltherapies #onlinenetworking #pharma #biotech #allogeneiccelltherapies

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

@FateThx Announces FDA Clearance of IND Application for FT538, First CRISPR-edited, iPSC-derived Cell Therapy
https://t.co/OOOlTMv7kT

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

FDA clears @Agentus_CellTX IND for allogeneic iNKT cell therapy
https://t.co/2lLhDyG0Fu

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

https://t.co/9jFimyOrJc

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

@AllogeneTx spotlights their off-the-shelf #CART contender ‘501 with a snapshot on CRs and no GVHD
https://t.co/KYBlqQRL4E

[The Allogeneic Cell Therapies Summit @AllogeneicCell]

The future of allogeneic therapies @LonzaPB
https://t.co/XwsH7iSKEx

[Targeted Oncology @TargetedOnc]

CAR T-cell therapies quickly burst into the spotlight of hematology-oncology disease management because of their potential to illicit deep and durable responses from patients whose disease is relapsed or refractory to multiple previous lines of therapy.
https://t.co/kXt3Wf9E7B